LabPulse.com staff writersLawsuitOxford Nanopore files for subpoenas, claims BGI Group contractual breachOxford Nanopore Technologies announced that it intends to sue BGI Group and its subsidiaries for breach of contractual obligations as well as potential breach of patent licensing.September 11, 2024Mergers & AcquisitionsLuminUltra acquires Genomadix Legionella test assetsLuminUltra has acquired the Legionella testing business assets of Genomadix, as well as the rights to develop and commercialize further assays and test methods.September 10, 2024MonkeypoxSeegene launches 3rd RUO mpox assayAfter introducing two research use only (RUO) mpox assays in August, Seegene has expanded its mpox assay line with a third RUO assay designed to address the spread of the mpox virus variant clade Ib currently prevalent in the mpox outbreak in Africa.September 10, 2024Artificial IntelligenceRoche adds new collaborative AI tools to cancer diagnostics open environmentRoche is integrating more than 20 new artificial intelligence (AI) algorithms from eight new collaborators into its Roche Digital Pathology Open Environment for cancer diagnostics.September 9, 2024AgreementA. Menarini, Nucleix sign distribution agreement for bladder cancer testA. Menarini Diagnostics and liquid biopsy firm Nucleix have signed a strategic partnership for the exclusive distribution of Nucleix's Bladder EpiCheck test.September 9, 2024KickbackFormer COO of COVID-19 test distributor sentenced for wire fraudThe former chief operating officer (COO) of a COVID-19 testing kit distributor was sentenced to more than six years in federal prison for embezzling more than $1.85 million in company funds.September 6, 2024Research GrantHudsonAlpha Institute gets $2.9M NIH grant for pediatric rare disease sequencingScientists at the HudsonAlpha Institute for Biotechnology in Huntsville, AL, have been awarded a five-year, $2.9 million U.S. National Institutes of Health (NIH) grant to identify genetic contributors to rare diseases in children.September 6, 2024ImmunoassaysRapid blood test for heart attack holds promise for shorter ED staysA rapid blood test that can distinguish heart attack in people presenting at emergency departments (EDs) with chest pain has been developed by researchers.September 5, 2024FinancingBillionToOne secures $140M financing agreement with Oberland CapitalMolecular diagnostics firm BillionToOne has signed a $140 million nondilutive financing agreement with Oberland Capital Management.September 5, 2024LawsuitEuropean Court rules for Illumina in jurisdictional appealThe European Court of Justice ruled that the European Commission did not have jurisdiction over Illumina's acquisition of Grail, reversing a ruling by a lower court that dismissed Illumina's appeal and overturning a €432 million ($477.8 million) fine.September 4, 2024Page 1 of 358Next PageTop StoriesMonkeypoxSeegene launches 3rd RUO mpox assayAfter introducing two research use only (RUO) mpox assays in August, Seegene has expanded its mpox assay line with a third RUO assay designed to address the spread of the mpox virus variant clade Ib currently prevalent in the mpox outbreak in Africa.Policy and RegulationHospital labs targeted in proposed Calif. hospital licensing regulationsResearch GrantHudsonAlpha Institute gets $2.9M NIH grant for pediatric rare disease sequencingClinical ChemistryADLM releases guidance for blood lipid assessment, lipoprotein testingSponsor ContentVisit our Molecular Diagnostics Community